65740-38-7 Usage
Chemical structure
A derivative of pyrazole with a chlorophenyl group attached to the 3-position of the pyrazole ring.
Potential pharmaceutical applications
Investigated for its potential use as an anti-inflammatory and antifungal agent.
Biological activity
Its structure and properties make it a valuable building block for the synthesis of other biologically active compounds.
Research interest
Of interest to researchers and pharmaceutical companies for its potential medicinal properties and ability to modulate biological pathways.
Chemical properties
As a derivative of pyrazole, it may exhibit similar chemical properties such as reactivity with electrophiles and nucleophiles.
Physical properties
The specific physical properties (e.g., melting point, boiling point, solubility) are not provided in the material, but they can be inferred based on the molecular structure and functional groups present.
Synthesis
The compound can be synthesized through various chemical reactions, likely involving the formation of the pyrazole ring and subsequent introduction of the chlorophenyl group.
Safety and handling
As with any chemical compound, appropriate safety measures should be taken when handling 1-(3-CHLOROPHENYL)-1H-PYRAZOL-3-AMINE, including the use of personal protective equipment and proper disposal methods.
Check Digit Verification of cas no
The CAS Registry Mumber 65740-38-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,7,4 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 65740-38:
(7*6)+(6*5)+(5*7)+(4*4)+(3*0)+(2*3)+(1*8)=137
137 % 10 = 7
So 65740-38-7 is a valid CAS Registry Number.
65740-38-7Relevant articles and documents
1,3-SUBSTITUED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LONG CHAIN FATTY ACIC LEVELS
-
Paragraph 257, (2018/06/30)
Disclosed are chemical entities which are compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein Formula (I) has the structure: R1a, R1b, R2, R3, R4a, R4b and Y are as defined herein. These chemical entities are useful for reduction of very long chain fatty acid levels. These chemical entities and pharmaceutically acceptable compositions comprising such chemical entities can be useful for treating various diseases, disorders and conditions, such as adrenoleukodystrophy (ALD).
Synthesis and antiulcer activity of (E)-5-[2-(3-pyridyl)ethenyl]-1H,7H-pyrazolo [1,5-a]pyrimidine-7-ones.
Doria,Passarotti,Sala,Magrini,Sberze,Tibolla,Ceserani,Castello
, p. 417 - 429 (2007/10/02)
A series of (E)-5-[2-(3-pyridyl)ethenyl]-1H,7H-pyrazolo-[1,5-a]pyrimidine-7-ones were synthesized and evaluated for the inhibition of stress-induced gastric ulcers in the rat after oral administration. Several molecules were found to be very active. The particularly interesting compound (E)-1-(3-chlorophenyl)-5-[2-(3-pyridyl)ethenyl]-1H,7H-pyrazolo[1,5-a]- pyrimidine-7-one was chosen for wider pharmacological investigation.
